CDK4 and neoplasm: As the percentage of CDK4 and MDM2 amplifications in low-grade central osteosarcoma and parosteal osteosarcoma are much higher than in high-grade osteosarcoma, most likely the CDK4/MDM2 amplified high-grade tumours represent progression from low grade osteosarcoma [53].